Aptose Biosciences Inc

Aptose Biosciences Inc

APTO

Get informed when a big investor buys or sells

+ Follow
Market Cap$4.36M
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Aptose Biosciences IncAptose Biosciences Inc0.8--16%--
$4.12

Current Fair Value

141% upside

Undervalued by 141% based on the discounted cash flow analysis.

Share Statistics

Market cap$4.36 Million
Enterprise Value$3.42 Million
Dividend Yield$- (-)
Earnings per Share$-10.41
Beta1.13
Outstanding Shares2,552,429

Return

Return on Equity-15.99%ROE
Return on Assets51.69%
Return on Invested Capital-1036.43%

Valuation & Multiples

P/E Ratio0.79P/E Ratio
PEG-0.79PEG
Price to Sales-Price to Sales
Price to Book Ratio-0.12Price to Book Ratio
Enterprise Value to Revenue-
Enterprise Value to EBIT0.64
Enterprise Value to Net Income0
Total Debt to Enterprise0.02
Debt to Equity0Debt to Equity

Revenue Sources

No data

Insider Trades

Last Earnings Call

Report Date
November 6, 2025
EPS Estimate
-
Average shareholder expectation
Revenue Estimate
-
Average shareholder expectation

Institutional Put/Call Ratio

Market sentiment based on institutional option activity.

Put/Call Ratio0.00000%
Total Calls-
Total Puts-

Institutional Ownership

Holdings and activity of institutional investors.

Ownership %0.98%0%
Total Invested$39,965▲ 11.76%
Investors Holding40%

ESG Score

No data

About Aptose Biosciences Inc

CEO: William Rice